Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Plakoglobin

From Wikipedia, the free encyclopedia
Mammalian protein found in Homo sapiens

JUP
Available structures
PDBOrtholog search:PDBeRCSB
List of PDB id codes

3IFQ

Identifiers
AliasesJUP, ARVD12, CTNNG, DP3, DPIII, PDGB, PKGB, Plakoglobin, junction plakoglobin, PG
External IDsOMIM:173325;MGI:96650;HomoloGene:1680;GeneCards:JUP;OMA:JUP - orthologs
Gene location (Human)
Chromosome 17 (human)
Chr.Chromosome 17 (human)[1]
Chromosome 17 (human)
Genomic location for JUP
Genomic location for JUP
Band17q21.2Start41,754,604bp[1]
End41,786,931bp[1]
Gene location (Mouse)
Chromosome 11 (mouse)
Chr.Chromosome 11 (mouse)[2]
Chromosome 11 (mouse)
Genomic location for JUP
Genomic location for JUP
Band11 D|11 63.47 cMStart100,259,784bp[2]
End100,288,589bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • skin of leg

  • skin of abdomen

  • mucosa of pharynx

  • nipple

  • gingival epithelium

  • skin of arm

  • human penis

  • vulva

  • skin of thigh

  • apex of heart
Top expressed in
  • lip

  • esophagus

  • corneal stroma

  • skin of back

  • muscle of thigh

  • skin of external ear

  • stomach

  • pyloric antrum

  • epithelium of stomach

  • yolk sac
More reference expression data
BioGPS
More reference expression data
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo /QuickGO
Orthologs
SpeciesHumanMouse
Entrez

3728

16480

Ensembl

ENSG00000173801

ENSMUSG00000001552

UniProt

P14923

Q02257

RefSeq (mRNA)
NM_002230
NM_021991
NM_001352773
NM_001352774
NM_001352775

NM_001352776
NM_001352777

NM_010593

RefSeq (protein)
NP_002221
NP_068831
NP_001339702
NP_001339703
NP_001339704

NP_001339705
NP_001339706

NP_034723

Location (UCSC)Chr 17: 41.75 – 41.79 MbChr 11: 100.26 – 100.29 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Plakoglobin, also known asjunction plakoglobin orgamma-catenin, is aprotein that in humans is encoded by theJUPgene.[5] Plakoglobin is a member of thecatenin protein family and homologous toβ-catenin. Plakoglobin is acytoplasmic component ofdesmosomes andadherens junctions structures located withinintercalated discs ofcardiac muscle that function to anchorsarcomeres and join adjacent cells incardiac muscle. Mutations in plakoglobin are associated witharrhythmogenic right ventricular dysplasia.

Structure

[edit]

Human plakoglobin is 81.7 kDa in molecular weight and 745 amino acids long.[6] TheJUP gene contains 13 exons spanning 17 kb on chromosome 17q21.[7] Plakoglobin is a member of thecatenin family, since it contains a distinct repeating amino acid motif called thearmadillo repeat.[5] Plakoglobin is highly similar toβ-catenin; both have 12armadillo repeats as well asN-terminal andC-terminal globular domains of unknown structure.[8] Plakoglobin was originally identified as a component ofdesmosomes, where it can bind to thecadherin family memberdesmoglein I. Plakoglobin also associates with classical cadherins such asE-cadherin; in that context, it was called gamma-catenin. Plakoglobin forms distinct complexes withcadherins anddesmosomal cadherins.

Function

[edit]
Simplified scheme of cell junctions. TJ, Tight junctions; AJ, Adherens junctions; D, Desmosomes; ZO, Zonula occludens; PG, Plakoglobin, PKP, Plakophilin; DP, Desmoplakin

Plakoglobin is a majorcytoplasmic component of bothdesmosomes andadherens junctions, and is the only known constituent common to submembranous plaques in both of these structures,[9] which are located at the intercalated disc (ICD) of cardiomyocytes. Plakoglobin linkscadherins to theactincytoskeleton. Plakoglobin binds to conserved regions ofdesmoglein anddesmocollin atintracellularcatenin-binding sites to assembledesmosomes.[10][11]

Plakoglobin is essential for normal development ofintercalated discs and stability ofcardiac muscle. Transgenic mice homozygous for a null mutation of theJUP gene die around embryonic day 12 from substantial defects inadherens junctions and a lack of functional desmosomes in the heart.[12][13] Further studies showed thatcardiac fibers obtained fromJUP-null embryonic mice had decreased passive compliance albeit normal attachment ofsarcomeres toadherens junctions.[14]

In additional studies, an induciblecardiac-specific plakoglobin knockout mice were generated. Transgenic mice displayed a similar phenotype asarrhythmogenic right ventricular cardiomyopathy patients, with loss ofcardiomyocytes,fibrosis and cardiac dysfunction, as well as alterations indesmosome protein content andgap junction remodeling. Hearts also exhibited increases inβ-catenin signaling.[15][16] Further investigations on the role ofβ-catenin and plakoglobin in the heart generated a double knockout of these two proteins. Mice exhibitedcardiomyopathy,fibrosis, conduction abnormalities andsudden cardiac death, presumably via spontaneous lethal ventriculararrhythmias. Mice also showed a decrease ingap junction structures atintercalated discs.[17]

Intracellular plakoglobin expression is controlled byWnt signaling and ubiquitin-proteasome-dependent degradation.Phosphorylation ofN-terminalSerines by a “destruction complex” composed ofglycogen synthase kinase 3β (GSK3β) and scaffold proteinsadenomatous polyposis coli (APC) andaxin targets plakoglobin for degradation.[18][19][20][31–33]. Thephosphorylated motif is recognized by β-TrCP, a ubiquitin ligase that targets plakoglobin 26S proteasome-dependent degradation.[21] Plakoglobin is alsoO-glycosylated near itsN-terminal destruction box.

Clinical significance

[edit]

Mutation of theJUP gene encoding plakoglobin has been implicated as one of the causes of thecardiomyopathy known asarrhythmogenic right ventricular dysplasia (ARVD) orarrhythmogenic right ventricular cardiomyopathy; mutations inJUP specifically causes anautosomal recessive form referred to asNaxos disease.[22][23][24] This form of was first identified in a small cluster of families on the Greek island ofNaxos. The phenotype of theNaxos disease variant ofARVD is unique in that it involves the hair and skin as well as the rightventricle. Affected individuals have kinky,wooly hair; there is also palmar and plantarerythema at birth that progresses tokeratosis as the palms and soles of the feet are used in crawling and walking.[25][26][27] These findings co-segregate 100% with the development ofARVD by early adolescence.

It has become clear thatARVD/ARVC is a disease of thecardiac muscledesmosome; advances in molecular genetics have illuminated this notion.[28][29][30][31][32][33][34][35][36]

Studies investigating the role of plakoglobin in disease pathology have found that suppression ofdesmoplakin expression bysiRNA led to thenuclear localization of plakoglobin, resulting in a reduction inWnt signaling via Tcf/Lef1 and ensued pathogenesis of ARVC.[37] Specifically, adipogenic factor expression was induced and cardiac progenitor cells at the epicardium were differentiated to adipocytes.[38]

Non-invasivecardiac screening identified T-wave inversion, abnormalities in rightventricular wall motion, and frequent ventricular extrasystoles as sensitive and specific markers of aJUP mutation.[39] Additional studies have shown that immunohistochemical analysis ofcardiac muscledesmosomal proteins is also a sensitive and specific diagnostic text forARVD/ARVC.[40]

Abnormal distribution of plakoglobin due to mutations in genes encoding forDesmoglein 1 and 3 have also been implicated inPemphigus vulgaris.[41][42]

Interactions

[edit]

Plakoglobin has been shown tointeract with:

See also

[edit]

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000173801Ensembl, May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000001552Ensembl, May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ab"Entrez Gene: JUP junction plakoglobin".
  6. ^"Protein sequence of human JUP (Uniprot ID: P14923)".Cardiac Organellar Protein Atlas Knowledgebase (COPaKB). Archived fromthe original on 24 September 2015. Retrieved3 July 2015.
  7. ^Whittock NV, Eady RA, McGrath JA (October 2000)."Genomic organization and amplification of the human plakoglobin gene (JUP)".Experimental Dermatology.9 (5):323–326.doi:10.1034/j.1600-0625.2000.009005323.x.PMID 11016852.S2CID 12956044.
  8. ^Stokes DL (October 2007)."Desmosomes from a structural perspective".Current Opinion in Cell Biology.19 (5):565–571.doi:10.1016/j.ceb.2007.09.003.PMC 2211412.PMID 17945476.
  9. ^Cowin P, Kapprell HP, Franke WW, Tamkun J, Hynes RO (September 1986). "Plakoglobin: a protein common to different kinds of intercellular adhering junctions".Cell.46 (7):1063–1073.doi:10.1016/0092-8674(86)90706-3.PMID 3530498.S2CID 45332970.
  10. ^Witcher LL, Collins R, Puttagunta S, Mechanic SE, Munson M, Gumbiner B, et al. (May 1996)."Desmosomal cadherin binding domains of plakoglobin".The Journal of Biological Chemistry.271 (18):10904–10909.doi:10.1074/jbc.271.18.10904.PMID 8631907.
  11. ^Troyanovsky RB, Chitaev NA, Troyanovsky SM (December 1996). "Cadherin binding sites of plakoglobin: localization, specificity and role in targeting to adhering junctions".Journal of Cell Science.109 (13):3069–3078.doi:10.1242/jcs.109.13.3069.PMID 9004041.
  12. ^Ruiz P, Brinkmann V, Ledermann B, Behrend M, Grund C, Thalhammer C, et al. (October 1996)."Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart".The Journal of Cell Biology.135 (1):215–225.doi:10.1083/jcb.135.1.215.PMC 2121015.PMID 8858175.
  13. ^Bierkamp C, Mclaughlin KJ, Schwarz H, Huber O, Kemler R (December 1996)."Embryonic heart and skin defects in mice lacking plakoglobin".Developmental Biology.180 (2):780–785.doi:10.1006/dbio.1996.0346.PMID 8954745.
  14. ^Isac CM, Ruiz P, Pfitzmaier B, Haase H, Birchmeier W, Morano I (January 1999). "Plakoglobin is essential for myocardial compliance but dispensable for myofibril insertion into adherens junctions".Journal of Cellular Biochemistry.72 (1):8–15.doi:10.1002/(sici)1097-4644(19990101)72:1<8::aid-jcb2>3.0.co;2-a.PMID 10025662.S2CID 23650188.
  15. ^Li J, Swope D, Raess N, Cheng L, Muller EJ, Radice GL (March 2011)."Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling".Molecular and Cellular Biology.31 (6):1134–1144.doi:10.1128/MCB.01025-10.PMC 3067899.PMID 21245375.
  16. ^Li D, Liu Y, Maruyama M, Zhu W, Chen H, Zhang W, et al. (December 2011)."Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy".Human Molecular Genetics.20 (23):4582–4596.doi:10.1093/hmg/ddr392.PMC 3209829.PMID 21880664.
  17. ^Swope D, Cheng L, Gao E, Li J, Radice GL (March 2012)."Loss of cadherin-binding proteins β-catenin and plakoglobin in the heart leads to gap junction remodeling and arrhythmogenesis".Molecular and Cellular Biology.32 (6):1056–1067.doi:10.1128/MCB.06188-11.PMC 3295003.PMID 22252313.
  18. ^Kodama S, Ikeda S, Asahara T, Kishida M, Kikuchi A (September 1999)."Axin directly interacts with plakoglobin and regulates its stability".The Journal of Biological Chemistry.274 (39):27682–27688.doi:10.1074/jbc.274.39.27682.PMID 10488109.
  19. ^Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P (March 1995)."The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin".The Journal of Biological Chemistry.270 (10):5549–5555.doi:10.1074/jbc.270.10.5549.PMID 7890674.
  20. ^Kikuchi A (February 2000). "Regulation of beta-catenin signaling in the Wnt pathway".Biochemical and Biophysical Research Communications.268 (2):243–248.doi:10.1006/bbrc.1999.1860.PMID 10679188.
  21. ^Sadot E, Simcha I, Iwai K, Ciechanover A, Geiger B, Ben-Ze'ev A (April 2000)."Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system".Oncogene.19 (16):1992–2001.doi:10.1038/sj.onc.1203519.PMID 10803460.
  22. ^Zhang Z, Stroud MJ, Zhang J, Fang X, Ouyang K, Kimura K, et al. (April 2015)."Normalization of Naxos plakoglobin levels restores cardiac function in mice".The Journal of Clinical Investigation.125 (4):1708–1712.doi:10.1172/JCI80335.PMC 4396479.PMID 25705887.
  23. ^Li D, Zhang W, Liu Y, Haneline LS, Shou W (March 2012)."Lack of plakoglobin in epidermis leads to keratoderma".The Journal of Biological Chemistry.287 (13):10435–10443.doi:10.1074/jbc.M111.299669.PMC 3322998.PMID 22315228.
  24. ^Rampazzo A (2006)."Genetic bases of arrhythmogenic right ventricular Cardiomyopathy".Heart International.2 (1): 17.doi:10.4081/hi.2006.17 (inactive 12 July 2025).PMC 3184660.PMID 21977247.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)
  25. ^Erken H, Yariz KO, Duman D, Kaya CT, Sayin T, Heper AO, et al. (October 2011). "Cardiomyopathy with alopecia and palmoplantar keratoderma (CAPK) is caused by a JUP mutation".The British Journal of Dermatology.165 (4):917–921.doi:10.1111/j.1365-2133.2011.10455.x.PMID 21668431.S2CID 31241849.
  26. ^Pigors M, Kiritsi D, Krümpelmann S, Wagner N, He Y, Podda M, et al. (May 2011)."Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity".Human Molecular Genetics.20 (9):1811–1819.doi:10.1093/hmg/ddr064.PMID 21320868.
  27. ^Cabral RM, Liu L, Hogan C, Dopping-Hepenstal PJ, Winik BC, Asial RA, et al. (June 2010)."Homozygous mutations in the 5' region of the JUP gene result in cutaneous disease but normal heart development in children".The Journal of Investigative Dermatology.130 (6):1543–1550.doi:10.1038/jid.2010.7.PMID 20130592.
  28. ^Marian AJ (2013). "On the diagnostic utility of junction plakoglobin in arrhythmogenic right ventricular cardiomyopathy".Cardiovascular Pathology.22 (5):309–311.doi:10.1016/j.carpath.2013.05.002.PMID 23806441.
  29. ^Lazzarini E, Jongbloed JD, Pilichou K, Thiene G, Basso C, Bikker H, et al. (April 2015)."The ARVD/C genetic variants database: 2014 update".Human Mutation.36 (4):403–410.doi:10.1002/humu.22765.hdl:11577/3157304.PMID 25676813.S2CID 29624191.
  30. ^Fressart V, Duthoit G, Donal E, Probst V, Deharo JC, Chevalier P, et al. (June 2010)."Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice".Europace.12 (6):861–868.doi:10.1093/europace/euq104.PMID 20400443.
  31. ^McNally E, MacLeod H, Dellefave-Castillo L (1993). "Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy". In Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds.).GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle.PMID 20301310.
  32. ^Bauce B, Nava A, Beffagna G, Basso C, Lorenzon A, Smaniotto G, et al. (January 2010). "Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia".Heart Rhythm.7 (1):22–29.doi:10.1016/j.hrthm.2009.09.070.PMID 20129281.
  33. ^den Haan AD, Tan BY, Zikusoka MN, Lladó LI, Jain R, Daly A, et al. (October 2009)."Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy".Circulation: Cardiovascular Genetics.2 (5):428–435.doi:10.1161/CIRCGENETICS.109.858217.PMC 2801867.PMID 20031617.
  34. ^Awad MM, Calkins H, Judge DP (May 2008)."Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy".Nature Clinical Practice. Cardiovascular Medicine.5 (5):258–267.doi:10.1038/ncpcardio1182.PMC 2822988.PMID 18382419.
  35. ^van Tintelen JP, Hofstra RM, Wiesfeld AC, van den Berg MP, Hauer RN, Jongbloed JD (May 2007). "Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?".Current Opinion in Cardiology.22 (3):185–192.doi:10.1097/HCO.0b013e3280d942c4.PMID 17413274.S2CID 24552922.
  36. ^Sen-Chowdhry S, Syrris P, McKenna WJ (November 2007)."Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy".Journal of the American College of Cardiology.50 (19):1813–1821.doi:10.1016/j.jacc.2007.08.008.PMID 17980246.
  37. ^Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, et al. (July 2006)."Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy".The Journal of Clinical Investigation.116 (7):2012–2021.doi:10.1172/JCI27751.PMC 1483165.PMID 16823493.
  38. ^Lombardi R, Marian AJ (May 2010)."Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells".Current Opinion in Cardiology.25 (3):222–228.doi:10.1097/HCO.0b013e3283376daf.PMC 2980568.PMID 20124997.
  39. ^Antoniades L, Tsatsopoulou A, Anastasakis A, Syrris P, Asimaki A, Panagiotakos D, et al. (September 2006)."Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis".European Heart Journal.27 (18):2208–2216.doi:10.1093/eurheartj/ehl184.PMID 16893920.
  40. ^van Tintelen JP, Hauer RN (July 2009). "Cardiomyopathies: New test for arrhythmogenic right ventricular cardiomyopathy".Nature Reviews. Cardiology.6 (7):450–451.doi:10.1038/nrcardio.2009.97.PMID 19554004.S2CID 20454940.
  41. ^Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Ruocco E, et al. (October 2001). "A possible role of catenin dyslocalization in pemphigus vulgaris pathogenesis".Journal of Cutaneous Pathology.28 (9):460–469.doi:10.1034/j.1600-0560.2001.028009460.x.PMID 11553312.S2CID 34380290.
  42. ^Mignogna MD, Pannone G, Lo Muzio L, Staibano S, Bucci E (May 2001). "Catenin dislocation in oral pemphigus vulgaris".Journal of Oral Pathology & Medicine.30 (5):268–274.doi:10.1034/j.1600-0714.2001.300503.x.PMID 11334462.
  43. ^abShibata T, Gotoh M, Ochiai A, Hirohashi S (August 1994). "Association of plakoglobin with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation".Biochemical and Biophysical Research Communications.203 (1):519–522.doi:10.1006/bbrc.1994.2213.PMID 8074697.
  44. ^Daniel JM, Reynolds AB (September 1995)."The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein or alpha-catenin".Molecular and Cellular Biology.15 (9):4819–4824.doi:10.1128/mcb.15.9.4819.PMC 230726.PMID 7651399.
  45. ^abSacco PA, McGranahan TM, Wheelock MJ, Johnson KR (August 1995)."Identification of plakoglobin domains required for association with N-cadherin and alpha-catenin".The Journal of Biological Chemistry.270 (34):20201–20206.doi:10.1074/jbc.270.34.20201.PMID 7650039.
  46. ^Roe S, Koslov ER, Rimm DL (June 1998)."A mutation in alpha-catenin disrupts adhesion in clone A cells without perturbing its actin and beta-catenin binding activity".Cell Adhesion and Communication.5 (4):283–296.doi:10.3109/15419069809040298.PMID 9762469.
  47. ^Obama H, Ozawa M (April 1997)."Identification of the domain of alpha-catenin involved in its association with beta-catenin and plakoglobin (gamma-catenin)".The Journal of Biological Chemistry.272 (17):11017–11020.doi:10.1074/jbc.272.17.11017.PMID 9110993.
  48. ^abHazan RB, Norton L (April 1998)."The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton".The Journal of Biological Chemistry.273 (15):9078–9084.doi:10.1074/jbc.273.15.9078.PMID 9535896.
  49. ^Kucerová D, Sloncová E, Tuhácková Z, Vojtechová M, Sovová V (December 2001). "Expression and interaction of different catenins in colorectal carcinoma cells".International Journal of Molecular Medicine.8 (6):695–698.doi:10.3892/ijmm.8.6.695.PMID 11712088.
  50. ^Kinch MS, Clark GJ, Der CJ, Burridge K (July 1995)."Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia".The Journal of Cell Biology.130 (2):461–471.doi:10.1083/jcb.130.2.461.PMC 2199929.PMID 7542250.
  51. ^Hinck L, Näthke IS, Papkoff J, Nelson WJ (June 1994)."Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly".The Journal of Cell Biology.125 (6):1327–1340.doi:10.1083/jcb.125.6.1327.PMC 2290923.PMID 8207061.
  52. ^Knudsen KA, Wheelock MJ (August 1992)."Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin".The Journal of Cell Biology.118 (3):671–679.doi:10.1083/jcb.118.3.671.PMC 2289540.PMID 1639850.
  53. ^Straub BK, Boda J, Kuhn C, Schnoelzer M, Korf U, Kempf T, et al. (December 2003)."A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells".Journal of Cell Science.116 (Pt 24):4985–4995.doi:10.1242/jcs.00815.PMID 14625392.
  54. ^Klingelhöfer J, Troyanovsky RB, Laur OY, Troyanovsky S (August 2000). "Amino-terminal domain of classic cadherins determines the specificity of the adhesive interactions".Journal of Cell Science.113 (16):2829–2836.doi:10.1242/jcs.113.16.2829.PMID 10910767.
  55. ^Lewalle JM, Bajou K, Desreux J, Mareel M, Dejana E, Noël A, et al. (December 1997). "Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro".Experimental Cell Research.237 (2):347–356.doi:10.1006/excr.1997.3799.hdl:2268/61990.PMID 9434630.
  56. ^Shasby DM, Ries DR, Shasby SS, Winter MC (June 2002). "Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin".American Journal of Physiology. Lung Cellular and Molecular Physiology.282 (6):L1330 –L1338.CiteSeerX 10.1.1.1000.5266.doi:10.1152/ajplung.00329.2001.PMID 12003790.
  57. ^Bannon LJ, Cabrera BL, Stack MS, Green KJ (November 2001)."Isoform-specific differences in the size of desmosomal cadherin/catenin complexes".The Journal of Investigative Dermatology.117 (5):1302–1306.doi:10.1046/j.1523-1747.2001.01512.x.PMID 11710948.
  58. ^Nieset JE, Sacco-Bubulya PA, Sadler TM, Johnson KR, Wheelock MJ (May 2000)."The amino- and carboxyl-terminal tails of (beta)-catenin reduce its affinity for desmoglein 2".Journal of Cell Science.113 (10):1737–1745.doi:10.1242/jcs.113.10.1737.PMID 10769205.
  59. ^Ozawa M, Terada H, Pedraza C (November 1995)."The fourth armadillo repeat of plakoglobin (gamma-catenin) is required for its high affinity binding to the cytoplasmic domains of E-cadherin and desmosomal cadherin Dsg2, and the tumor suppressor APC protein".Journal of Biochemistry.118 (5):1077–1082.doi:10.1093/jb/118.5.1077.PMID 8749329.
  60. ^Kowalczyk AP, Navarro P, Dejana E, Bornslaeger EA, Green KJ, Kopp DS, et al. (October 1998). "VE-cadherin and desmoplakin are assembled into dermal microvascular endothelial intercellular junctions: a pivotal role for plakoglobin in the recruitment of desmoplakin to intercellular junctions".Journal of Cell Science.111 (20):3045–3057.doi:10.1242/jcs.111.20.3045.PMID 9739078.
  61. ^Kowalczyk AP, Bornslaeger EA, Borgwardt JE, Palka HL, Dhaliwal AS, Corcoran CM, et al. (November 1997)."The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes".The Journal of Cell Biology.139 (3):773–784.doi:10.1083/jcb.139.3.773.PMC 2141713.PMID 9348293.
  62. ^Li Y, Yu WH, Ren J, Chen W, Huang L, Kharbanda S, et al. (August 2003). "Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein".Molecular Cancer Research.1 (10):765–775.PMID 12939402.
  63. ^Chen X, Bonne S, Hatzfeld M, van Roy F, Green KJ (March 2002)."Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling".The Journal of Biological Chemistry.277 (12):10512–10522.doi:10.1074/jbc.M108765200.PMID 11790773.
  64. ^Fuchs M, Müller T, Lerch MM, Ullrich A (July 1996)."Association of human protein-tyrosine phosphatase kappa with members of the armadillo family".The Journal of Biological Chemistry.271 (28):16712–16719.doi:10.1074/jbc.271.28.16712.PMID 8663237.
  65. ^Besco JA, Hooft van Huijsduijnen R, Frostholm A, Rotter A (October 2006). "Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT)".Brain Research.1116 (1):50–57.doi:10.1016/j.brainres.2006.07.122.PMID 16973135.S2CID 23343123.
  66. ^Pashmforoush M, Pomiès P, Peterson KL, Kubalak S, Ross J, Hefti A, et al. (May 2001). "Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy".Nature Medicine.7 (5):591–597.doi:10.1038/87920.PMID 11329061.S2CID 1781328.

Further reading

[edit]

External links

[edit]
Human
Microfilaments
andABPs
Myofilament
Actins
Myosins
Other
Other
Intermediate
filaments
Type 1/2
(Keratin,
Cytokeratin)
Epithelial keratins
(soft alpha-keratins)
Hair keratins
(hard alpha-keratins)
Ungrouped alpha
Not alpha
Type 3
Type 4
Type 5
Microtubules
andMAPs
Tubulins
MAPs
Kinesins
Dyneins
Microtubule organising proteins
Microtubule severing proteins
Other
Catenins
Membrane
Other
Nonhuman
Proteins ofepithelium
Lateral/cell–cell
Basal/cell–matrix
Apical
Retrieved from "https://en.wikipedia.org/w/index.php?title=Plakoglobin&oldid=1316947373"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp